PC3 cells, previously described as androgen-receptor-negative, express lower androgen receptor levels than LNCaP cells and are a model for castration-resistant androgen-independent prostate cancer cells, while LNCaP cells serve as a model for androgen-dependent prostate cancer cells [57]. The gene discussed is AR; the disease is prostate carcinoma.